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AbstrACt
Objective Test effectiveness of an educational 
intervention for general practitioners (GPs) on quality of life 
and depression outcomes for patients.
Design Double-blind, cluster randomised controlled trial.
setting General practices in Australia between 2007 and 
2010.
Participants General practices were randomly allocated 
to the waitlist (n=37) or intervention (n=66) group, in 
a ratio of 1:2. A total of 2030 (1478 intervention; 552 
waitlist) community-dwelling participants aged 75 years 
or older were recruited via 168 GPs (113 intervention; 55 
waitlist).
Interventions A practice-based academic detailing 
intervention led by a peer educator that included: (1) 
training in use of the GP assessment of cognition dementia 
screening instrument; (2) training in diagnosis and 
management based on Royal Australian College of General 
Practitioners Dementia Guidelines; (3) addressing GPs’ 
barriers to dementia diagnosis; and (4) a business case 
outlining a cost-effective dementia assessment approach.
Outcome measures Primary outcome measures 
were patient quality of life and depression; secondary 
outcome measures were: (1) sensitivity and specificity 
of GP identification of dementia; (2) referral to medical 
specialists and/or support services; (3) patient satisfaction 
with care; and (4) carer quality of life, depression and 
satisfaction with care.
results The educational intervention had no significant 
effect on patient quality of life or depression scores 
after 12 months. There were however improvements in 
secondary outcome measures including sensitivity of GP 
judgement of dementia (p=0.002; OR 6.0, 95% CI 1.92 to 
18.73), satisfaction with GP communication for all patients 
(p=0.024; mean difference 2.1, 95% CI 0.27 to 3.93) and 
for patients with dementia (p=0.007; mean difference 
7.44, 95% CI 2.02 to 12.86) and enablement of carers 
(p=0.0185; mean difference 24.77, 95% CI 4.15 to 45.40).
Conclusion Practice-based academic detailing did not 
improve patient quality of life or depression scores but did 
improve detection of dementia in primary care and patient 
satisfaction with GP communication.
trial registration number ACTRN12607000117415; Pre-
results.
IntrODuCtIOn 
Dementia is a complex and variable condi-
tion that affects cognition, behaviour and 
the person’s ability to perform everyday 
tasks. The number of people living with 
dementia worldwide is currently estimated 
at 46.8 million. This number is expected to 
double by 2030 and almost triple by 2050, due 
to the increasing longevity of the world popu-
lation.1 As the number of people living with 
strengths and limitations of this study
 ► Individual and contemporaneous home assess-
ments were completed for each participant, rather 
than relying on administrative data such as general 
practitioner (GP) records.
 ► The educational intervention was specifically de-
signed to address a number of identified barriers to 
GP identification and management of dementia and 
was also personalised to each GP.
 ► Evaluation measures included detection and man-
agement of dementia and patient and carer out-
comes, thus capturing the last (and essential) 
translational output from the intervention.
 ► Findings relating to carers must be interpreted with 
caution due to their relatively high (and differential) 
loss to follow-up.
 ► GP learning was not directly measured, and the ad-
herence to dementia guidelines was assessed by 
self-reporting of dementia related tests and refer-
rals by GPs.  on 11 N
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dementia increases, a shift from a specialist-led approach 
to a primary care-based model would enable improved 
diagnosis and dementia care pathways to be implemented 
in an affordable manner.2 Primary care is ‘more local, 
more holistic and personalised, and more comprehen-
sive, integrated and continuous’ than secondary care,2 
and thus well placed to provide dementia identification 
and management and integration across primary health 
and social care services. This accords with the WHO 
identifying integrated care for the elderly at the centre 
of a new initiative.3 Primary care physicians can attain 
similar outcomes to specialists when given responsibility 
for dementia care,4 with further improvements attainable 
given appropriate training, mentoring and resources.
Timely diagnosis and management of dementia is 
desired by many patients with dementia and their carers5–7 
to improve their access to interventions and support at the 
most appropriate time.8 Diagnostic disclosure of memory 
problems is associated with better physical and environ-
mental quality of life (QoL) in people with dementia9 
and is not associated with poorer health-related QoL.10 
A timely diagnosis may help people with dementia, and 
their carers, understand and cope with the challenging 
symptoms of dementia, fulfil short-term goals and facil-
itate planning for the future while they are still compe-
tent to do so.11 12 Referral can be made for social support 
services and specialist treatments, including anti-Alzhei-
mer’s medications that may slow the course of cognitive 
decline.2 4
General practitioners (GPs) fail to identify about 
50% of mild dementia cases in the community13–15 and 
demonstrate gaps in recorded diagnostic processes 
against guidelines.16 A number of barriers to diagnosis 
of dementia can be attributed to patient, carer, GP and 
systemic factors.17 18 The gradual decline in functional 
ability in the early stages of dementia can be attributed 
to ‘normal’ ageing by persons with the condition or those 
close to them and by their GPs.19–21 The stigma associ-
ated with dementia may delay help seeking.22 Only one 
in five people who mention memory problems to their 
GP have dementia,15 so the GP may choose to observe 
such a patient, rather than proceeding early to what may 
be perceived as an expensive and alarming diagnostic 
assessment. Other GP-related barriers to early diagnosis 
include lack of knowledge12 and/or confidence,19 20 23–26 
the reality that dementia diagnosis is difficult due to slow 
and fluctuating onset and overlap of symptoms with other 
diseases, lack of a definitive diagnostic test25 and the 
perception of dementia diagnosis as a specialist domain.27 
No medication exists that will effectively reverse or halt 
the progress of these disorders, and GPs may not concep-
tualise social and system support for ongoing cognitive 
decline as therapeutic, and this nihilism may also hinder 
management.28 29
GPs’ detection and management of dementia have 
been addressed in several educational interventions with 
varying success.18 30–34 Large seminar-based interven-
tions have limited effectiveness28; however, educational 
interventions that incorporated active small-group 
learning tasks have improved detection of dementia.32 33 
The most effective educational strategies in the general 
practice setting incorporate an academic detailing 
approach35 36 that presents evidence-based content in an 
engaging and clinically relevant manner while allowing 
flexibility to address the needs and concerns of individual 
practitioners.34 37
The objective of this study was to determine the effec-
tiveness of an educational intervention that included an 
academic detailing visit to each practice using model 
cases to illustrate case identification and management 
and designed to address individual GP needs. The 
barriers to GP diagnosis and management of dementia 
addressed were: the limited time available for consulta-
tion, attitudinal factors and lack of relevant knowledge. 
Further discussion with the GP elicited and addressed 
any additional barriers. Primary outcomes were patient 
focused (QoL and depression scores); secondary outcome 
measures included GP and carer factors.
MethODs
study design
This study (the Ageing in General Practice trial) was a 
cluster randomised trial with a 12-month follow-up. A 
parallel design was employed. Practices with participating 
GPs were randomly allocated in a ratio of 2:1 to either 
an intervention or waitlist group. Intervention practices 
(n=66) received a dementia-related educational peer 
outreach visit and completed two patient audits with 
feedback. Waitlist practices (n=37) completed two audits 
without feedback and were mailed the then-current Royal 
Australian College of General Practitioners (RACGP) 
Dementia Guidelines at 12 months.38 The rationale and 
study design have been reported in detail previously.39
Participants
Practices eligible for inclusion in the study were located 
within 30 km of each urban study site headquarters 
(Sydney, Newcastle, Melbourne and Adelaide) or from 
the rural study site of Bendigo or its surrounding towns; 
had community dwelling patients aged ≥75 years; and 
used a computerised patient database. GPs that had been 
involved in development of the project were excluded. 
The cluster randomisation has been described else-
where.39 Briefly, a list of all eligible practices was compiled 
and sent to an independent party, the Centre for Epide-
miology and Biostatistics at the University of Newcastle 
(CCEB), for randomisation. CCEB provided the approach 
order for the practices. A project nurse or GP visited each 
practice to explain the project and recruit GPs prior to 
allocation of the practice to intervention or waitlist. Prac-
tices were stratified by site and by size of practice as either 
standard or large (>5 GPs working in the practice) and 
then allocated to intervention or waitlist in a ratio of 2:1 
in randomly rotated blocks of 3 and 6. Of the 2800 GPs 
approached, 168 (6%) entered the study. This sample was 
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representative based on comparison with demographics 
of all active recognised GPs in Australia.40
GPs sent letters of invitation to all patients who met the 
inclusion criteria, inviting them to participate in the study. 
Those who agreed to participate responded by returning 
a consent form to the local study site. Patients eligible for 
inclusion in the study were aged ≥75 years, had visited 
their GP within the last 24 months and were able to speak 
and understand English. The exclusion criteria were 
Parkinson’s disease, multiple sclerosis, motor neuron 
disease, central nervous system inflammation, psychotic 
symptoms prior to recruitment, developmental disability, 
progressive malignancy or substance abuse, too sick to 
complete the study or resident of aged care facility at 
entry to the study.
Carers of patients were eligible for the study if they had 
been identified as a carer or support person by a patient 
scoring <80 on the revised Cambridge Cognitive Examina-
tion (CAMCOG-R),41 had prior consent from the patient 
with dementia for his or her carer to participate and were 
able to speak and understand English. Eligible carers 
were provided with an information pack and a letter of 
invitation. Those who agreed to participate responded by 
returning a consent form to the local study site.
Patient and public involvement
Local reference groups at the Newcastle and Sydney sites 
included representatives of Alzheimer’s Australia (now 
Dementia Australia) to provide patients’ and carers’ 
perspectives in best practice management of dementia. 
The reference groups (that also included members of 
local divisions of general practice, geriatricians and 
practice nurses) provided stakeholder input into the 
study protocol, requested wording changes to proposed 
information and consent forms, considered the RACGP 
dementia guidelines and adapted them for local use, for 
example, developed a list of local services for patients 
with dementia.
Acceptability of the interview process and dementia 
screening were measured. Participants were asked to 
complete a short survey, which was returned to the local 
study site in a reply-paid envelope to avoid bias due to the 
presence of the nurse or practice staff.
Results of the interview process were provided to 
patients via their GP to ensure that they were understood 
and discussed as appropriate.
Intervention
The intervention in this study consisted of an educa-
tional academic detailing session conducted at each GP’s 
surgery by a trained peer medical or nurse educator. 
GPs completed an audit of their patients prior to the 
education in order to obtain a baseline measure of their 
dementia diagnosis rates and management practices. The 
educational session that followed included: (1) instruc-
tion in the use of the General Practitioner assessment of 
Cognition (GPCOG) dementia screening instrument42; 
(2) an interactive presentation on dementia diagnosis, 
diagnostic workup and management based on the 
RACGP Dementia Guidelines38; (3) an exploration of the 
GP’s perceived barriers to dementia diagnosis; and (4) 
a business case outlining the cost recovery potential of 
dementia assessment in terms of the Australian govern-
ment’s Medicare Benefits Schedule. The systemic issue 
of lack of time in the GP consultation was addressed by 
training the GPs in the use of a brief screening instru-
ment and by discussing potential methods of obtaining 
assistance from the practice nurse. Case studies were 
used to illustrate appropriate management including 
behavioural, environmental and pharmacological strat-
egies; when to refer to support services (eg, aged care 
assessment team, memory assessment unit, Alzheimer’s 
Australia, Meals on Wheels and respite care), solic-
itor or specialists; and carer health. Intervention GPs 
were provided with a full copy of the RACGP Dementia 
Guidelines, as well as an A4-sized summary poster at the 
conclusion of the academic detailing visit. A second audit 
was held at 12 months in order to determine the effect 
of the educational intervention on outcome measures 
while allowing sufficient time for the GP to have seen 
the patient several times. Following the second audit, 
GPs were provided with the results of the comprehensive 
nurse assessments conducted at baseline and 12 months 
and offered an opportunity for self-reflection and discus-
sion with their academic detailer.
Waitlist GPs completed two audits (baseline and 12 
months) of their patients. Waitlist GPs were mailed a 
written summary of their patient’s home assessment and 
the RACGP Dementia Guidelines after completion of the 
12-month audit.
Data collection
At baseline, waitlist and intervention GPs received a list 
of their participating patients to audit. This audit task 
required GPs to provide their clinical judgement in 
relation to each patient’s dementia status using one of 
four options: no dementia, possible dementia, probable 
dementia and definite dementia. GPs completed a supple-
mentary audit for any patients with possible, probable or 
definite dementia to gather data on memory-related tests 
and investigations performed (ie, paper-and-pencil test 
for cognition or depression, pathology and radiology) 
and referrals to services (including care services, memory 
assessment services and the Aged care Assessment Team 
and medical specialists). Differential diagnosis and iden-
tification of reversible causes were also requested. This 
audit was repeated at 12 months. Although GPs were 
aware that there were intervention and waitlist groups, 
they were not informed of their group allocation; both 
groups participated in the audit.
Patient and carer assessments were conducted at their 
home by a research nurse at baseline and 12 months. Infor-
mation was collected from patients and carers relating 
to their personal and social circumstances including 
socioeconomic status using the Index of Relative Social 
Advantage and Disadvantage,43 QoL, depression and 
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satisfaction with GP care. The cognitive function of 
patients was assessed using the GPCOG and CAMCOG-R. 
All nurses were trained in administration of each instru-
ment and adhered to a standardised interview protocol 
to minimise interviewer bias. The specific patient charac-
teristics collected and the instruments and criteria used 
have been described previously.9 15 If requested by the GP, 
the nurse also conducted a ‘75+Health Assessment’, an 
item that can be rebated under the Australian Medicare 
system. These data were not used by the study but were 
returned to the GP for his or her use. Research nurses 
and patients were blinded to the group allocation for the 
entire study.
At the completion of the baseline assessment, each 
patient received a letter prepared by the project manager, 
directing them to obtain an appointment with his or her 
GP. Patients in the waitlist group were seen by their GP 
to review their 75+Health Assessment only. For patients 
in the intervention group, the GP followed up on the 
75+Health Assessment, readministered the GPCOG and 
provided care in the light of their recent education. 
Results of the GP-administered GPCOG were forwarded to 
the local study site headquarters. GPs were not informed 
of the outcome of the research nurse assessment until 
after the 12-month audit in order to determine the effec-
tiveness of the GP education process on GP diagnosis and 
management of patients over the 12-month study period. 
Following their GP visit, patients and carers in the inter-
vention group were asked to complete a short satisfaction 
survey regarding the use of the GPCOG by their GP. The 
survey was returned immediately to administrative staff 
at the GP surgery or to the study team via a reply-paid 
envelope.
study outcomes
The outcome measures (collected at baseline and 12 
months) used to examine the effect of the educational 
intervention were:
Primary outcomes
 ► World Health Organisation Brief Quality of Life 
Instrument (WHOQoL-BREF) scores for patients44 
(higher score indicative of higher QoL).
 ► Geriatric Depression Scale (GDS)45 scores for patients 
(score greater than 5 indicative of depression).
Secondary outcomes
 ► Sensitivity and specificity of GP identification of 
dementia compared with the CAMCOG-R, a brief 
neuropsychological test battery from The Cambridge 
Examination for Mental Disorders of the Elderly.41 A 
cut-off point of 79/80 differentiates between those 
having dementia and those not having dementia with 
93% sensitivity and 87% specificity.46 For the purposes 
of this study, a CAMCOG-R score of less than 80 was 
used as an indicator of dementia.
 ► The number of GP reported test types (pathology, 
pencil-and-paper and imaging) and referrals 
(specialist and care support services) related to 
dementia.
 ► WHOQoL-BREF scores for carers.
 ► Beck Depression Inventory47 scores for carers (higher 
total scores over 13 indicative of more severe depres-
sive symptoms).
 ► General Practice Assessment Questionnaire Version 
2 (GPAQ)48 scores for patients and carers. The 
GPAQ domains used in this study were related to GP 
communication (eight questions) and patient enable-
ment (three questions related to patients’ ability to 
understand and cope with their illness or problem) 
following consultation with their GP. Mean domain 
scores were transformed into a percentage of the 
maximum possible score, with higher scores indica-
tive of higher satisfaction or enablement.
 ► GP identification of differential diagnoses.
 ► GP identification of reversible causes of dementia (eg, 
depression, vitamin B12 deficiency, hypothyroidism 
and adverse drug reaction).
 ► Acceptability of memory screening using the GPCOG.
 ► Specialist and care services accessed.
Due to the low reporting of differential diagnoses or 
treatment of reversible causes of dementia by GPs at 
baseline and 12 months, the effect of the intervention on 
these secondary outcome measures39 could not be eval-
uated. Likewise, the dementia management practices of 
GPs during the study period, such as referral to specialists 
or care support services, and the services actually accessed 
by participants were not effectively captured. The effect 
of the intervention on these secondary outcomes related 
to management of dementia could therefore not be 
determined.
sample size
We calculated that a total sample size of 150 dementia 
patients would have 90% power to detect a mean differ-
ence of 7.0 between waitlist and intervention in the 
change in prescore and postscore on any of the four 
domain scales of the WHOQOL-BREF with a type I 
error rate of 0.05. The SD used was 18.5, and the overall 
correlation between prescore and postscore was assumed 
to be 0.7. The study would also have 90% power to detect 
a mean difference of 0.9 on the 15-point GDS, assuming 
an SD of 2.442 and using the same set of assumptions for 
alpha and correlations.
The estimated sample size was adjusted for correlation 
due to clustering of patients within GP practices. Clus-
tering within GP practices was discounted, as each GP was 
expected to have very few patients in the study. Assuming 
an intraclass correlation coefficient of 0.05 and an average 
cluster size of five patients per practice, the design effect 
is 1.2 and a total of 180 patients would be required.
An allocation of two patients in the intervention 
group for each patient in the control group also allowed 
comparisons within the intervention group related to 
the benefits and acceptability of a screening or case-
finding approach to dementia diagnosis (to be reported 
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separately). Therefore, 68 patients in the waitlist control 
group and 135 patients in the intervention group were 
required.
We allowed for a 15% drop out over 12 months in this 
elderly patient group. Thus, based on a dementia preva-
lence of approximately 10% in Australians aged over 75 
years, we aimed to recruit a total of 2400 participants.
statistical analyses
Sensitivity of the GP’s diagnosis was calculated as the 
percentage of patients that the GP correctly classified 
as having dementia. Specificity was calculated as the 
percentage of patients that the GP correctly classified as 
not having dementia. The difference in sensitivity of GP 
diagnosis of dementia between the waitlist and interven-
tion groups was tested by fitting a generalised estimating 
equation (GEE) model (specifically a logistic regression) 
to the population with CAMCOG <80. The outcome in 
the model was whether the GP’s diagnosis at the 12-month 
audit agreed with the classification given by the CAMCOG 
at 12 months. The predictor variable was group (inter-
vention or waitlist), and the clustering variable was GP 
practice. Site was included as a categorical covariate. A 
similar model was used to test the difference in specificity 
between the groups by fitting a logistic regression GEE to 
the population with CAMCOG ≥80 at baseline.
For all other outcome measures, the average score was 
compared between intervention and waitlist groups using 
a linear regression GEE. The predictor variable of interest 
was group, and the clustering variable was GP practice. 
Site was included as a categorical covariate. Baseline 
scores were also included as a predictor.
results
Characteristics of participants
Of 2030 community-dwelling participants aged 75 years 
or older recruited via 168 GPs (table 1), 43 in the waitlist 
and 124 in the intervention group had dementia diag-
nosed as per the CAMCOG. The baseline characteristics 
and outcome measures for GP, patient and carer partici-
pants are shown in tables 1 and 2.
The 12-month assessment was completed by 97% of GPs 
(98% waitlist; 96% intervention), 79% of patients (75% 
waitlist; 80% intervention) and 63% of carers (71% waitlist; 
61% intervention) who entered the study (figure 1).
Primary outcome measures
Outcome measures were examined for all patients and 
separately for patients with CAMCOG-R dementia. In 
both populations, there was no significant difference in 
depression (all patients: p=0.683; patients with dementia: 
Table 1 Characteristics of GPs, patients and carers in the waitlist and intervention groups at baseline
Class or mean (SD) Waitlist Intervention
Patient characteristics (n=552) (n=1478)
Gender, n (%)* Male 259 (47) 671 (45)
Female 293 (53) 805 (55)
  Age (years) Mean (SD) 81.2 (4.4) 81.3 (4.2)
  IRSAD Mean (SD) 6.7 (2.5) 7.1 (2.5)
  CAMCOG score Mean (SD) 90.6 (7.8) 90.0 (8.2)
CAMCOG diagnosis, n (%) Impaired 43 (7.8) 124 (8.4)
Not impaired 505 (92) 1352 (92)
Carer characteristics (n=21) (n=90)
  Gender, n (%) Male 6 (29) 25 (28)
Female 15 (71) 65 (72)
  Age (years) Mean (SD) 70.3 (12.8) 73.0 (16.3)
  IRSAD Mean (SD) 6.9 (2.2) 6.5 (2.5)
GP characteristics (n=55) (n=113)
  Gender, n (%)* Male 28 (58) 63 (58)
Female 20 (42) 46 (42)
  Age (years) Mean (SD) 51.5 (9.9) 50.4 (8.5)
  Practice size, n (%) Solo 10 (22) 17 (16)
2–4 GPs 12 (27) 38 (36)
More than 5 GPs 23 (51) 52 (49)
  Number of patients in study Mean (SD) 10.0 (6.6) 13.1 (11.6)
*Gender was not disclosed by all patient or GP participants.
CAMCOG, Cambridge Cognitive Examination; GP, general practitioner; IRSAD, Index of Relative Social Advantage and Disadvantage.
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p=0.333) or QoL domain scores (all patients: p=0.488 
(physical), p=0.318 (psychological), p=0.959 (social), 
p=0.627 (environmental); patients with dementia: 
p=0.186 (physical), p=0.133 (psychological), p=0.730 
(social), p=0.766 (environmental)) for the waitlist and 
intervention groups at 12 months (table 3).
secondary outcome measures
Detection of dementia
The percentage of patients with CAMCOG-R dementia 
who were correctly identified by the GP (as having 
possible, probable or definite dementia) was similar in 
the waitlist (43%) and intervention (45%) groups at base-
line (table 4). At 12 months following a single educational 
visit in the intervention group and prior to feedback on 
the baseline audit, there was an increase (to 65%) in the 
percentage of patients who were correctly identified as 
having dementia in the intervention group but a decrease 
(to 29%) in the waitlist group (table 4). After adjusting 
for baseline values, the sensitivity of GP judgement of 
dementia was significantly higher in the intervention than 
the waitlist group at 12 months (p=0.002; OR 6.0, 95% 
CI 1.92 to 18.73). This means that GPs who had received 
training in the value of diagnosing dementia and in the 
use of a screening instrument were more likely to detect 
dementia than GPs who did not receive the training.
Approximately 90% of patients without CAMCOG-R 
dementia were correctly identified by waitlist and inter-
vention GPs at baseline and 12 months. That is, the spec-
ificity of GP judgement of dementia was approximately 
90% at baseline and 88% at 12 months in both the wait-
list and intervention groups (table 4). The lack of any 
significant difference in specificity between the groups 
at 12 months (p=0.530) indicates that the higher sensi-
tivity in the intervention group was not at a significant 
cost to specificity. The number of diagnostic assessment 
test types (pencil-and-paper, pathology and radiology) 
and referrals (specialist and services) per patient was 
recorded at baseline (table 2) and 12 months (table 3) for 
those patients with a GP judgement of dementia. There 
was no difference between the intervention and waitlist 
group in the number of tests or referrals per patient at 
baseline (tests: p=0.05; referrals: p=0.53) or 12 months 
(tests: p=0.973; referrals: p=0.429).
Satisfaction with care
Satisfaction with GP communication was higher in the 
intervention group compared with control at 12 months 
for all patients (p=0.024; mean difference 2.1, 95% CI 
0.27 to 3.93) and for patients with CAMCOG-R dementia 
(p=0.007; mean difference 7.44, 95% CI 2.02 to 12.86).
Of the 245 patients in the intervention group who 
returned their survey on acceptability of the GPCOG 
screening test administered by their GP, 68.4% liked the 
examination and a further 30.3% were neutral; 78.3% 
felt reassured that the GP had checked their memory and 
concentration, while less than 1% felt irritated or very 
irritated by the examination.
Table 2 Baseline outcome measures of patients, dementia 






Patient measures (n=552) (n=1478)
GDS 1.9 (1.9) 2.1 (2.1)
WHOQoL-BREF
  Physical 70.4 (15.3) 69.5 (15.0)
  Psychological 72.1 (12.9) 70.8 (12.6)
  Social 79.7 (13.6) 78.8 (13.2)
  Environmental 81.4 (10.8) 80.6 (11.4)
GPAQ
  Communication 81.4 (15.5) 80.5 (14.4)
  Enablement 67.7 (31.8) 66.0 (32.1)
GP management of 
dementia patients*
(n=63) (n=192)
Number of tests per patient 
(0—3)
0.79 1.13






Accessed memory services 
(% yes)
6 (14) 13 (12)
GDS 3.5 (3.2) 3.3 (2.8)
WHOQoL-
  Physical 66.45 (15.94) 63.80 (14.98)
  Psychological 67.44 (13.71) 64.80 (12.56)
  Social 73.58 (12.90) 76.65 (12.69)
  Environmental 76.04 (10.57) 74.60 (14.01)
GPAQ
  Communication 74.4 (14.2) 75.8 (15.1)
  Enablement 57.0 (33.7) 60.2 (34.6)
Carer measures (n=21) (n=90)
Beck Depression Inventory 10.3 (8.6) 8.5 (6.3)
WHOQoL-BREF
  Physical 69.6 (16.7) 70.2 (13.8)
  Psychological 68.4 (14.4) 69.0 (10.9)
  Social 76.0 (19.2) 77.1 (12.2)
  Environmental 77.5 (12.5) 77.2 (11.6)
GPAQ
  Communication 67.9 (21.1) 78.4 (16.8)
  Enablement 50.0 (35.8) 61.2 (36.4)
*Participants with GP audit of possible, probable or 
definite dementia.
†Participants with CAMCOG <80.
CAMCOG, Cambridge Cognitive Examination; GDS, 
Geriatric Depression Scale; GP, general practitioner; 
GPAQ, General Practice Assessment Questionnaire. 
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Secondary outcome measures for carers of patients with 
CAMCOG-R dementia
Carer outcomes measures at 12 months (adjusted for 
baseline and site) are presented in table 3. There was 
no significant difference in depression or QoL domain 
scores for the waitlist and intervention groups at 12 
months (table 3). Carers in the intervention group had 
a higher GPAQ enablement score (p=0.019; mean differ-
ence 24.77, 95% CI 4.15 to 45.40) at 12 months.
DIsCussIOn
Principal findings
This study examined the effects of a dementia-related 
educational intervention for GPs. The primary outcome 
measures related to QoL and depression scores for 
patients and carers were not affected by the interven-
tion. There were, however, significant findings for 
several secondary outcome measures, including a signif-
icant improvement in the identification of patients with 
dementia by GPs in the intervention compared with the 
waitlist group. The higher sensitivity of GP clinical judge-
ment of dementia in the intervention group was not at a 
significant cost to specificity, which remained similar in 
the two groups. Satisfaction with GP communication was 
higher at follow-up in the intervention group compared 
with the waitlist group for all patients and specifically for 
those with dementia. Carer satisfaction with GP communi-
cation was not significantly different between the groups 
Figure 1 Flow of participants through the study. Baseline patient interviews were conducted from May 2007 to November 
2009; 12-month interviews were conducted from August 2008 to December 2010. CAMCOG, Cambridge Cognitive 
Examination; GP, general practitioner.
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at 12 months; however, carers of people with dementia 
in the intervention group reported higher enablement 
(ie, better ability to understand and cope with their situ-
ation). We found no difference in GP management of 
dementia between intervention and control groups based 
on the number of tests and referrals to specialists or care 
services. It may be that the intervention had a stronger 
emphasis on identification of dementia than on these 
aspects of management due to the time spent addressing 
attitudinal barriers to dementia identification.







Difference at 12 months 
adjusted for baseline and site
Mean (95% CI) or OR (95% CI)
Adjusted p 
value (GEE)
Patient measures (n=416*) (n=1188*)
GDS 2.1 (2.2) 2.1 (2.0) −0.04 (−0.22 to 0.14) 0.6832
WHOQoL – BREF:
  Physical 68.7 (15.6) 68.8 (14.9) 0.45 (−0.83 to 1.73) 0.4880
  Psychological 71.5 (12.9) 71.0 (12.3) 0.67 (−0.65 to 2) 0.3183
  Social 77.7 (12.9) 77.1 (12.2) −0.04 (−1.5 to 1.42) 0.9593
  Environmental 81.1 (10.8) 79.9 (11.6) −0.35 (−1.77 to 1.07) 0.6272
GPAQ
  Communication 78.3 (16.4) 79.7 (15.0) 2.1 (0.27 to 3.93) 0.0242
  Enablement 63.4 (34.9) 64.3 (32.5) 1.23 (−3.71 to 6.18) 0.6248
GP management of dementia patients* (n=44) (n=166)
Number of tests per patient (0—3) 0.64 0.55 OR: 1.01 (0.52 to 1.97) 0.9729
Number of referrals per patient (0—2) 0.16 0.18 OR: 1.50 (0.55 to 4.10) 0.4285
Dementia patient measures† (n=34) (n=82)
Accessed memory services (% yes) 3 (11%) 9 (13%) OR: 2.15 (0.32 to 14.49) 0.4333
GDS 3.1 (2.9) 2.7 (2.0) −0.41 (−1.24 to 0.42) 0.3335
WHOQoL-BREF
  Physical 65.4 (16.0) 66.0 (12.6) 2.55 (−1.23 to 6.34) 0.1864
  Psychological 66.4 (15.0) 65.2 (12.6) 2.63 (−0.8 to 6.07) 0.1334
  Social 73.6 (13.2) 75.0 (11.6) 0.79 (−3.7 to 5.29) 0.7297
  Environmental 77.1 (13.6) 75.6 (12.2) 0.54 (−3.01 to 4.09) 0.7660
GPAQ
  Communication 72.6 (18.6) 78.6 (15.3) 7.44 (2.02 to 12.86) 0.0072
  Enablement 55.8 (36.1) 63.9 (33.3) 5.65 (−8.68 to 19.98) 0.4395
Carer measures (n=15) (n=55)
Beck Depression Inventory 8.2 (6.2) 7.3 (4.4) −2.67 (−6.93 to 1.59) 0.2195
WHOQoL-BREF:
  Physical 76.3 (10.4) 69.8 (12.3) −5.15 (−13.02 to 2.72) 0.1995
  Psychological 71.4 (7.6) 69.0 (11.3) 1.58 (−2.56 to 5.71) 0.4556
  Social 73.8 (16.0) 73.3 (13.5) 5.88 (−2.89 to 14.66) 0.1889
  Environmental 81.0 (6.5) 77.6 (11.1) −1.53 (−5.77 to 2.70) 0.4786
GPAQ
  Communication 75.0 (13.2) 77.1 (19.0) 1.91 (−8.02 to 11.85) 0.7060
  Enablement 42.9 (33.8) 64.1 (37.1) 24.77 (4.15 to 45.40) 0.0185
*Participants with GP audit of possible, probable or definite dementia at 12 months.
†Participants with CAMCOG <80 at 12 months.
CAMCOG, Cambridge Cognitive Examination; GDS, Geriatric Depression Scale; GEE, generalised estimating equation; GP, general 
practitioner; GPAQ, General Practice Assessment Questionnaire.
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Comparison with other studies
Considering how little is known about the trajectory 
of QoL across the stages of dementia or its responsive-
ness to change49; it was an optimistic choice of primary 
outcome measure for a GP-based educational interven-
tion. QoL is a complex multidimensional construct, with 
no strong common or unique predictors identified across 
the stages of dementia (reviewed by ref 50). The other 
primary outcome measure for this study, patient depres-
sion score, is consistently but moderately associated with 
decreased QoL in dementia, especially in the early stage50 
but also difficult to address in people with dementia, with 
both psychological and pharmacological approaches to 
treatment having mixed and marginal effects (reviewed 
by ref 51). Although improvement in patient-related 
outcomes such as QoL and depression scores may be 
the ultimate goal, and are certainly important outcome 
measures, their responsiveness to changes in GP in diag-
nosis and management may be slow and dependent on 
the effectiveness of downstream support services. Most 
other GP-based interventions for dementia have used 
behaviour, performance and practice of the health profes-
sional as the primary study outcomes.30–34
The improvement of dementia detection compared 
with waitlist by GPs following our practice-based educa-
tional intervention is consistent with previous studies 
using a small-group workshop, decision support software 
or an interactive seminar approach.32 33 The GPCOG 
proved to be an effective element of the intervention.52 
Adherence to management guidelines was not improved 
by any of these interventions but was improved in a 
study that combined the educational intervention with 
appointment of dementia care managers.53 Despite the 
lack of change in adherence to management guidelines 
in our study, in terms of test ordering and referrals, the 
improvement in satisfaction with GP communication 
and/or enablement in patients and carers in the inter-
vention compared with the waitlist suggest some other 
changes in GP management of dementia patients not 
measured here. An external audit process conducted by 
independent clinical research staff may be more effec-
tive at capturing dementia-related management during 
GP clinical encounters than the GP self-report by audit 
process used in this study.
Satisfaction with GP communication encompasses 
a number of factors (including provision of adequate 
time, exploring patients’ needs, listening, explaining, 
giving information and sharing decisions) and is a strong 
predictor of overall satisfaction with primary care.54 Effec-
tive GP–patient communication can potentially have a 
significant impact on patients’ QoL; it is positively asso-
ciated with psychological QoL in people with dementia 
and with physical, psychological, social and environ-
mental QoL in elderly patients without dementia.9 Despite 
the higher satisfaction with GP communication found in 
this study, there was no concomitant difference in QoL 
measures for patients or carers at 12 months as a result of 
the intervention. Importantly though, the improvement 
in the rate of dementia identification in the interven-
tion group compared with the waitlist did not result in a 
decline in any of the QoL domains, a concern expressed 
previously by both carers and GPs.55–57
The improvement in enablement scores for carers of 
people with dementia in the intervention, compared 
with the waitlist group, at 12 months indicates carers’ 
increased capacity and confidence with respect to treat-
ment and self-management. Since enablement is related 
more to the communication and empathy characteristics 
of the GP than to the fulfilment of patient or carer expec-
tation regarding service outcomes,54 58 there may have 
been some change in the GP management of patients 
with dementia that was not captured by monitoring rates 
of tests and referrals. Unfortunately, the improvement in 
enablement scores was not accompanied by any differ-
ence in QoL scores for carers. This is consistent with 
the literature; there is little evidence that support-based 
interventions for caregivers of people with dementia are 
effective.59–62
strengths and limitations
This study is strengthened by the use of individual and 
contemporaneous home assessment of each participant, 
meaning that the project assessed current dementia 
status using a standardised instrument (CAMCOG-R) 
rather than relying on administrative data such as GP 
records, commonly used in GP research. The educational 
intervention used activities that had proved effective in 
previous research; was specifically designed to address 
Table 4 Sensitivity and specificity of the GP audit (compared with CAMCOG-R, a standardised instrument used to measure 
the extent of dementia) in the waitlist and intervention groups at baseline and 12 months
Baseline 12 months Intervention versus waitlist












Sensitivity, n (%)† 18 (43) 55 (45) 7 (29) 47 (65) 6.00 (1.92 to 18.73) 0.0020
Specificity, n (%)‡ 429 (91) 1196 (90) 272 (88) 844 (88) 0.79 (0.38 to 1.65) 0.5298
*Adjusted for baseline and site.
†Patients with CAMCOG-R score <80 that were judged by GP as having possible, probable or definite dementia.
‡Patients with CAMCOG-R score ≥80 that were judged not to have dementia by their GP.
CAMCOG-R, revised Cambridge Cognitive Examination; GEE, generalised estimating equation; GP, general practitioner.
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a number of identified barriers to GP identification 
and management of dementia; and was personalised to 
each GP. An additional strength is that the effect of the 
intervention was assessed on detection and management 
of dementia and on patient and carer outcomes, thus 
capturing the last (and essential) translational output 
from the intervention.
While retention of GPs in the study was excellent, a 
limitation was the 6% higher than expected drop-out 
rate for patients and the relatively high (and differential) 
loss to follow-up of carers. The results must, therefore, 
be interpreted with caution. The observed improvement 
in GP identification of dementia in the intervention 
group compared with waitlist did not lead to differences 
in management in terms of referrals to medical special-
ists or care services. Since GP learning was not directly 
measured, and the adherence to dementia guidelines was 
assessed by self-reporting of dementia-related tests and 
care and specialist referrals by GPs, it is possible that some 
may have improved their practice but did not record it.63
The relatively short follow-up period for this study is 
also a limitation. An educational intervention combined 
with structured care management resulted in a reduction 
in the decline of health-related QoL for patients with 
dementia after 18 months but not 12 months53 suggesting 
that improvements to QoL measures may manifest slowly.
Implications for clinicians and policymakers
This trial illustrates that a simple academic detailing 
intervention, though more expensive than large group 
teaching, can produce significant improvements in GP 
dementia identification and that these can translate into 
improved communication with consumers and enable-
ment for carers of people with dementia. Given the huge 
impact that dementia will have on health services in the 
future, and the benefits to both the individual and the 
health system from timely diagnosis and carer enable-
ment, this is an important finding for both clinicians and 
policy makers.
Future research and conclusion
This trial raises a number of questions for future research. 
One concerns the best way to improve GP management 
of dementia according to guidelines. Dementia manage-
ment is complex and ranges from diagnostic assessment 
through to a primary care team approach to those living 
with dementia in the community and on to management 
in residential aged care. Further research on how best to 
do this, and also how best to teach it, is urgently needed. 
Another question concerns the long-term effects of better 
identification of dementia; further longitudinal studies in 
primary care are needed for this. Funders should consider 
longitudinal studies of dementia in primary care that 
capture the experience of consumers and carers from 
prior to diagnosis, as in this study, and throughout their 
journey to explore the complex interactions between 
personal, health system and broader community factors 
on the dementia pathway.
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